Treating patients with semaglutide -- an anti-diabetic medication -- can halt and even reverse liver disease, according to a ...

A single intravitreal injection of UBX1325 (foselutoclax ... a secondary analysis of a trial of three different anti-VEGF drugs demonstrated persistent diabetic macular edema following monthly ...

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...

A daily pill from drugmaker Eli Lilly has shown similar effectiveness at helping people reduce blood sugar levels and lose weight compared to leading injectable ... free anti-obesity drug could ...

D Molecular Therapeutics (4DMT) has received the regenerative medicine advanced therapy (RMAT) designation from the FDA for ...

Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...

Despite greater weight loss from surgery, cancer risk reduction was similar between the two groups. After accounting for weight differences, the injectable drugs showed a 41-percent lower cancer risk ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

Injectable GLP-1 drugs have become gamechangers for treating obesity and Type 2 diabetes. Now ... It expects the anti-obesity version of the pill to be approved by the FDA first — likely ...

D-150 is a potential backbone therapy that is designed to provide multiyear sustained delivery of anti-VEGF (aflibercept and ...

The 559 study participants had not taken any anti-diabetic medications for at ... advantage in weight loss that Lilly’s oral drug shows over injectable Ozempic. But he added that injectables ...